Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer
暂无分享,去创建一个
Cristina Garibaldi | Roberto Orecchia | Federica Cattani | Raffaella Cambria | Cristiana Fodor | Dario Zerini | R. Orecchia | C. Garibaldi | R. Cambria | F. Serafini | B. Jereczek-Fossa | G. Pedroli | F. Cattani | D. Zerini | C. Fodor | Barbara A. Jereczek-Fossa | Flavia Serafini | Guido Pedroli
[1] R. Orecchia,et al. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. , 2009, International journal of radiation oncology, biology, physics.
[2] M. Schwaiger,et al. Effects of Irradiation on the [Methyl-3H]Choline Uptake in the Human Prostate Cancer Cell Lines LNCaP and PC3 , 2008, Strahlentherapie und Onkologie.
[3] D. Zips,et al. Prostate Cancer: Biological Dose Considerations and Constraints in Tele- and Brachytherapy , 2007, Strahlentherapie und Onkologie.
[4] M. Valenti,et al. Transabdominal Ultrasonography, Computed Tomography and Electronic Portal Imaging for 3-Dimensional Conformal Radiotherapy for Prostate Cancer , 2007, Strahlentherapie und Onkologie.
[5] Marnix G Witte,et al. IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. , 2007, Medical physics.
[6] X. Li,et al. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Barbara Alicja Jereczek-Fossa,et al. Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] R. Sweeney,et al. Single-Institution Results of Primary External-Beam Radiation for the Treatment of T1–T3 Prostate Cancer , 2007, Strahlentherapie und Onkologie.
[9] Giuseppe Iaccarino,et al. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. , 2007, International journal of radiation oncology, biology, physics.
[10] Matthias Guckenberger,et al. Intensity-Modulated Radiotherapy (IMRT) of Localized Prostate Cancer , 2007, Strahlentherapie und Onkologie.
[11] Matthias Guckenberger,et al. Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate , 2006, Strahlentherapie und Onkologie.
[12] Joos V Lebesque,et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.
[13] G. Sanguineti,et al. Does Treatment of the Pelvic Nodes with IMRT Increase Late Rectal Toxicity over Conformal Prostate-Only Radiotherapy to 76 Gy? , 2006, Strahlentherapie und Onkologie.
[14] P. Georg,et al. Inverse Planning – a Comparative Intersystem and Interpatient Constraint Study , 2006, Strahlentherapie und Onkologie.
[15] G. Arcangeli,et al. A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. , 2006, International journal of radiation oncology, biology, physics.
[16] Michel Bolla,et al. Guidelines for primary radiotherapy of patients with prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] V. Budach,et al. Influence of Organ at Risk Definition on Rectal Dose-Volume Histograms in Patients with Prostate Cancer Undergoing External-Beam Radiotherapy , 2006, Strahlentherapie und Onkologie.
[18] Radhe Mohan,et al. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. , 2006, International journal of radiation oncology, biology, physics.
[19] C. Hess,et al. A Prospective Three–Dimensional Analysis about the Impact of Differences in the Clinical Target Volume in Prostate Cancer Irradiation on Normal–Tissue Exposure , 2005, Strahlentherapie und Onkologie.
[20] G. Gustafson,et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[21] B. Lind,et al. Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer , 2005, Strahlentherapie und Onkologie.
[22] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[23] F Foppiano,et al. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] Gary Luxton,et al. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. , 2004, International journal of radiation oncology, biology, physics.
[25] Radhe Mohan,et al. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[26] S. Webb,et al. Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] Roberto Orecchia,et al. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] A. Niemierko,et al. Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. , 2002, Medical physics.
[29] Franca Foppiano,et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[30] C. Abbou,et al. EAU guidelines on prostate cancer. , 2009, European urology.
[31] G J Kutcher,et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.
[32] D P Dearnaley,et al. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. , 2001, International journal of radiation oncology, biology, physics.
[33] R. Orecchia,et al. Analysis of pelvis and abdomenal conformal radiotherapy using TCP and NTCP models , 2001 .
[34] W. De Gersem,et al. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. , 2000, International journal of radiation oncology, biology, physics.
[35] C. Ling,et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. , 2000, International journal of radiation oncology, biology, physics.
[36] A Fogliata,et al. Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability calculations. , 2000, Acta oncologica.
[37] Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization. , 1999, International journal of radiation oncology, biology, physics.
[38] S. Fosså,et al. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. , 1999, International journal of radiation oncology, biology, physics.
[39] L. Gras,et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.
[40] R Calandrino,et al. Variations of tumor control and rectum complication probabilities due to random set-up errors during conformal radiation therapy of prostate cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] Steve Webb. Converting 3d Dose to Biological Outcomes: Tumour Control Probability (Tcp) And Normal-Tissue-Complication Probability (Ntcp) , 1997 .
[42] S. Webb. The Physics of Conformal Radiotherapy: Advances in Technology , 1997 .
[43] M M Urie,et al. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. , 1996, International journal of radiation oncology, biology, physics.
[44] L. Verhey,et al. The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. , 1996, International journal of radiation oncology, biology, physics.
[45] M van Herk,et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.
[46] M. Oldham,et al. Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] S Webb,et al. A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[48] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[49] M G Kahn,et al. Objective evaluation of radiation treatment plans. , 1993, Proceedings. Symposium on Computer Applications in Medical Care.
[50] P. Rubin,et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.
[51] R. Mohan,et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.
[52] J. Purdy,et al. Three-dimensional treatment planning considerations for prostate cancer. , 1991, International journal of radiation oncology, biology, physics.
[53] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[54] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[55] J. Lyman. Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.
[56] D. McShan,et al. Quality assurance review program for radiotherapy in a cooperative group , 1981 .